Topics

AbbVie Stays Busy While Working to Complete Allergan Acquisition

20:00 EDT 10 Oct 2019 | BioSpace

As the $63 billion acquisition of Allergan by Chicago-based AbbVie slowly churns through the Federal Trade Commission (FTC) process, the company continues to make the news. Here’s a look.

Original Article: AbbVie Stays Busy While Working to Complete Allergan Acquisition

NEXT ARTICLE

More From BioPortfolio on "AbbVie Stays Busy While Working to Complete Allergan Acquisition"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...